Nanoco Leads the way in Taking Cutting Edge Research to the Marketplace as Commercial Products

Nanoco Technologies is unique in the nanomaterials market as a company that manufacture large quantities of quantum dots and partner major R&D and blue-chip industrial organisations in the development of quantum dot applications.  A flagship example of the UK’s ability to transform world-class research into cutting edge business, as recognized by the government organisation, UK Trade & Investment (UKTI) who asked Nanoco Technologies’ CEO, Michael Edelman to deliver a Keynote speech to an international audience at the UK NanoForum 2007 held in London on 27 November 2007.

Michael presented a case study on Nanoco Technologies showing how the company and its patented nanotechnology platform have grown from a University of Manchester spin-out to become an independent company enabling the quantum dot market and competing in the global marketplace to be the quantum dot supplier of choice for all application developers.

Nanoco solves the problem of scale manufacturing of quantum dots and leads the world in semi-conductor nanomaterials with a focus on next generation, heavy metal free quantum dots.

“We make strategic partnerships with global application developers and have substantive co-development contracts in place”, said Michael Edelman, “Support from UKTI has been key to our success. I was delighted to be asked to speak at this international nanotechnology conference, a great platform to show our strengths and to acknowledge the support that UKTI have given to help get us where we are in the global marketplace.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.